Biological
IHV01 clinical trials
Also written IHV01.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
National Institute of Allergy and Infectious Diseases (NIAID) (2) · U.S. Army Medical Research and Development Command (1)
Often tested with
Tested in the same studies.
A244 (1) · Monophosphoryl lipid A (1) · Saponin QA-21V1 (1)
Studies
Open first, then newest update. How each study uses IHV01 is read from its arms, and is right about nine times in ten.
Testing it · 3
- HIV Vaccine in HIV-uninfected AdultsCompletedPhase 1U.S. Army Medical Research and Development CommandNCT04658667Written as IHV01
- Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult ParticipantsWithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT04041674Written as IHV01 Protein
- Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected AdultsWithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03505060Written as IHV01